EEG Hemispheric Asymmetry as a Predictor and Correlate of Short-term Response to Clozapine Treatment in Schizophrenia

Shagass C. An electrophysiological view of schizophrenia. Biol Psychiat 1976;11: 3.

Small J. EEG in schizophrenia and affective disorder. In: Hughes JR Wilson WP (eds). EEG and Evoked Potentials in Psychiatry and Behavioral Neurology. Boston: Butterworth; 1983: 25–44.

Nuwer M. Quantitative EEG: II. Frequency analysis and topographic mapping in clinical settings. J Clin Neurophysiol 1988;5: 45–85.

Prichep L John E. QEEG profiles of psychiatric disorders. Brain Topogr 1992;4: 249–257.

Kennard M. The EEG in schizophrenia. In: Wilson WP (ed). Applications of Electroencephalography in Psychiatry. Durham NC: Duke University Press; 1965: 168–184.

Itil T. Qualitative and quantitative EEG findings in schizophrenia. Schiz Bull 1977;3: 61–79.

Flor-Henry P. Central dynamics, laterality and psychopathology: A commentary. In: Takahashi R Flor-Henry P Gruzelier J Niwa S (eds). Cerebral Dynamics, Laterality and Psychopathology, Amsterdam: Elsevier; 1987: 3–22.

Miyauchi T Tanaka K Hagimoto H Miura T Kishimoto H Matsushita M. Computerized EEG in schizophrenic patients. Biol Psychiat 1990;28: 488–494.

Elbert T Lutzenberger W Rockstroh B Berg P Cohen R. Physical aspects of the EEG in schizophrenics. Biol Psychiat 1992;32: 595–606.

John E Prichep L Alper K Quantitative electrophysiological characteristics and subtyping of schizophrenia. Biol Psychiat 1994;36: 801–826.

Merrin E Fein G Floyd T Yingling C. EEG asymmetry in schizophrenic patients before and during neuroleptic treatment. Biol Psychiat 1986;21: 455–464.

Buchsbaum M Cappellati J Coppola R Regal F King P van Kammen O. New methods to determine the CNS effects of antigeriatric compounds: EEG topography and glucose use. Drug Div Res 1982;2: 489–496.

Morihisa J Duffy F Wyatt R. Brain electrical activity mapping (BEAM) in schizophrenic patients. Arch Gen Psychiat 1983;40: 719–728.

Morstyn R Duffy F McCarley R. Altered topography of EEG spectral content in schizophrenia. Electroencephalogr Clin Neurophysiol 1983;56: 263–271.

Guenther W Breitling D Banquet J Marcie P Rondot P. EEG mapping of left hemisphere dysfunction during motor performance in schizophrenia. Biol Psychiat 1986;21: 249–262.

Karson C Coppola R. Morisha J, Weinberger D. Computed electroencephalographic activity mapping in schizophrenia. Arch Gen Psychiat 1987;44: 514–517.

Etevenon P Pidoux P Rioux P. Intra- and interhemispheric EEG differences quantified by spectral analysis: Comparative study of two groups of schizophrenics and a control group. Acta Scand 1979;60: 57–68.

Etevenon P. Intra- and inter-hemispheric changes in alpha intensities in EEGs of schizophrenic patients versus matched controls. Biol Psychiat 1984;19: 247–256.

Gaebel W Ulrich G. Topographical distribution of absolute alpha power in the EEG and psychopathology in schizophrenic outpatients. Acta Psychiat Scand 1988;77: 390–397.

Merrin E Floyd T. Negative symptoms and EEG alpha activity in schizophrenic patients. Schiz Res 1992;8: 11–20.

Itil T Marasa J Saletu B Davis S Mucciard A. Computerized EEG: Predictor of outcome in schizophrenia. J Nerv Ment Dis 1975;160: 188–253.

Itil T Shapiro D Schneider S Francis J. Computerized EEG as a predictor of drug response in treatment resistant schizophrenics. J Nerv Ment Dis 1981;169: 629–637.

Czobor P Volavka J. Pretreatment EEG predicts short-term response to haloperidol treatment. Biol Psychiat 1991;30: 927–942.

Small J Milstein V Small I Miller M Kellams J Corsaro C. Computerized EEG profiles of haloperidol, chlorpromazine, clozapine and placebo in treatment resistant schizophrenia. Clin Electroencephalogr 1987;18: 124–136.

Goldman-Rakic P Selemon L. Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schiz Bull 1997;23: 437–458.

Haber S Fudge J. The interface between dopamine neurons and the amygdala: Implications for schizophrenia. Schiz Bull 1997;23: 471–482.

Braff D Swerdlow N. Neuroanatomy of schizophrenia. Schiz Bull 1977;23: 509–512.

Frith C. Functional brain imaging of the neuropathology of schizophrenia. Schiz Bull 1977;23: 525–527.

Kane J Honeyfeld G Singer J Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine. Arch Gen Psychiat 1988;45: 789–796.

Czobor P Volavka J. Quantitative electroencephalogram examination of effects of risperidone in schizophrenic patients. J Clin Pharmacopsychiat 1993;13: 332–342.

Kay S Opler L Lindenmayer J. Reliability and validity of the positive and negative syndrome scale in schizophenria. Psychiat Res 1988;23: 99–110.

Kay S Opler L Lindenmayer J. The positive and negative scale (PANSS): Rationale and standardization. Brit J Psychiat 1989;155: 59–65.

John E Prichep P Easton P. Normative data banks and neurometrics: Basic concepts, methods and results of norm constructions. In: Gevins A Rémond A (eds). Methods of Analyzing Bioelectric and Magnetic Signals. EEG Handbook of Electroencephalography and Clinical Neurophysiology. Revised Series, Vol 2. New York: Elsevier Science; 1987: 449–495.

Fenton G Fenwick P Dollimore J EEG spectral analysis in schizophrenia. Br J Psychiatry 1980;136: 445–455.

Lacono W. Bilateral electrodermal habituation-dishabituation and resting EEG in remitted schizophrenics. J Nerv Ment Dis 1982;170: 91–101.

Gunther W Breitting D. Predominant sensorimotor area left hemisphere dysfunction in schizophrenia measured by brain electrical activity mapping. Biol Psychiat 1985;42: 329–334.

Matousek M Capone C Okawa M. Measurement of the inter-hemispheral differences as a diagnostic tool in psychiatry. Acta Biol Psychiat 1981;6: 76–80.

Shagass C Roemer R Straumanis J. Relationships between psychiatric diagnosis and some quantitative EEG variables. Arch Gen Psychiat 1983;39: 1423–1435.

Goldstein L. Some relationships between quantified hemispheric EEG and behavioral states in man. In: Gruzelier J Flor-Henry P (eds). Hemisphere Asymmetries of Function in Psychopathology. Amsterdam: Elsevier; 1979: 237–254.

D'Elia G Jacobson L von Knorring L Changes in psychopathology in relation to EEG variables and visual averaged evoked responses (VAER) in schizophrenic patients with penfluridol or thiothixene. Acta Psychiat Scand 1977;55: 309–318.

Kemali D Vacca L Marciano F CEEG findings in schizophrenics, depressives, obsessives, heroin addicts and normals. Adv Biol Psychiat 1981;6: 17–28.

Flor-Henry P. Lateralized temporal-limbic dysfunction and psychopathology. Ann NY Acad Sci 1976;280: 777–797.

Coger R Dymond A Serafetinides E. Electroencephalographic similarities between chronic alcoholics and chronic, nonparanoid schizophrenics. Arch Gen Psychiat 1979;36: 91–94.

Serafetinides E Coger R Martin J Schizophrenic symptomatology and cerebral dominance patterns: A comparison of EEG, AER, and BPRS measures. Compr Psychiat 1981;22: 218–225.

Reynolds G. Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia. Nature 1983;305: 527–529.

Gruzelier J. Functional neuropsychophysiological asymmetry in schizophrenia: A review and reorientation. Schiz Bull 1999;25: 91–120.

Gruzelier J Wilson L Liddiard D Peters E Pusavat L. Cognitive asymmetry patterns in schizophrenia: Active and withdrawn syndromes and sex differences as moderators. Schiz Bull 1999;25: 349–362.

Inguar D Franzen G. Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta Psychiat Scand 1974;4: 425–462.

Buchsbaum M Enguar D Kessler R Cerebral glucography with position tomography: Use in normal subjects and in patients with schizophrenia. Arch Gen Psychiat 1982;39: 251–259.

Daniel D Weinberger D Jones D The effect of amphetamine on regional cerebral flow during cognitive activation in schizophrenia. J Neurosci 1991;11: 1907–1917.

Okubo Y Suhara T Suzuki K Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature 1997;385: 634–636.

Weinberger D, Implications of the normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiat 1987;44: 660–669.

Frith C. Functional brain imaging and the neuropathology of schizophrenia. Schiz Bull 1997;23: 525–527.

Friston K Frith C. Schizophrenia: A disconnection syndrome?. Clin Neurosci 1995;3: 89–97.

Fletcher P Frith C Grasby P Friston K Dolan R. Local and distributed effect of apomorphine on fronto-temporal function in acute unmedicated schizophrenia. J Neurosci 1996;16: 7055–7062.

Manschreck T Redmond D Candela S Maher B. Effects of clozapine on psychiatric symptoms, cognition and functional outcome in schizophrenia. J Neuropsychiat Clin Neurosci 1999;11: 481–489.

Fitton A Heel R. Clozapine: A review of its pharmacological properties and therapeutic use in schizophrenia. Drugs 1990;40: 722–747.

Coward D. General pharmacology of clozapine. Brit J Psychiat 1992; 160 (Suppl 17): 3–11.

Freudenreich O Weiner R. Clozapine-induced electroencephalogram changes as a function of clozapine serum levels. Biol Psychiat 1997;42: 132–137.

Gunther W Baqhai T Naber D Spatz R Hippius H. EEG alterations and seizures during treatment with clozapine: A retrospective study of 283 patients. Pharmacopsychiatry 1993;26: 69–74.

Haring C Neudorfer C Schwitzer J EEG alterations in patients treated with clozapine in relation to plasma levels. Phamacology 1994;114: 97–100.

Malow B Reese K Sato S Bogard P Malhotra A Pickar D. Spectrum of EEG abnormalities during clozapine treatment. Electroencephalogr Clin Neurophysiol 1994;91: 205–211.

Welch J Manschreck T Redmond D. Clozapine-induced seizures and EEG changes. J Neuropsychiat Clin Neurosci 1994;6: 250–256.

Pilley S Stoll A Weiss M EEG abnormalities before clozapine therapy predict a good clinical response to clozapine. Ann Clin Psychiat 1996;8: 1–5.

Risby E Epstein C Jewart R Clozaine-induced EEG abnormalities and clinical response to clozapine. J Neuropsychiat Clin Neurosci 1995;7: 466–470.

Treves I Neufeld M. EEG abnormalities in clozapine-treated schizophrenic patients. Europ Neuropsychopharm 1996;6: 93–94.

Denney D Stevens J. Clozapine and seizures. Biol Psychiat 1995;37: 427–433.

Stevens J. Clozapine: The yin and yang of seizures. Biol Psychiat 1995;37: 425–426.

Itil T Itil K. Quantitative EEG brain mapping in psychotropic drug development, drug treatment, and monitoring. Am J Ther 1995;2: 359–367.

Galderisi S Mucci A Bucci P Mignone M Maj M. Multilead quantitative EEG profile of clozapine in resting and vigilance-controlled conditions. Psychiat Res 1996;67: 113–122.